Brief for the Generic Pharmaceutical Association in Support of Petitioner

Brief for the Generic Pharmaceutical Association in Support of Petitioner PDF Author:
Publisher:
ISBN:
Category :
Languages : en
Pages : 0

Get Book Here

Book Description

Brief for the Generic Pharmaceutical Association in Support of Petitioner

Brief for the Generic Pharmaceutical Association in Support of Petitioner PDF Author:
Publisher:
ISBN:
Category :
Languages : en
Pages : 0

Get Book Here

Book Description


Brief for the Generic Pharmaceutical Association in Support of Respondents

Brief for the Generic Pharmaceutical Association in Support of Respondents PDF Author:
Publisher:
ISBN:
Category :
Languages : en
Pages : 0

Get Book Here

Book Description


Brief for Generic Pharmaceutical Association and America's Health Insurance Plans in Support of Respondent

Brief for Generic Pharmaceutical Association and America's Health Insurance Plans in Support of Respondent PDF Author:
Publisher:
ISBN:
Category :
Languages : en
Pages : 0

Get Book Here

Book Description


Brief for the Pharmaceutical Research and Manufacturers of America and the Advanced Medical Technology Association in Support of Petitioner

Brief for the Pharmaceutical Research and Manufacturers of America and the Advanced Medical Technology Association in Support of Petitioner PDF Author:
Publisher:
ISBN:
Category :
Languages : en
Pages : 0

Get Book Here

Book Description


Generic drug entry prior to patent expiration an FTC study

Generic drug entry prior to patent expiration an FTC study PDF Author:
Publisher: DIANE Publishing
ISBN: 1428951938
Category :
Languages : en
Pages : 129

Get Book Here

Book Description


Making Medicines Affordable

Making Medicines Affordable PDF Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309468086
Category : Medical
Languages : en
Pages : 235

Get Book Here

Book Description
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.

Research Handbook on the Economics of Intellectual Property Law

Research Handbook on the Economics of Intellectual Property Law PDF Author: Ben Depoorter
Publisher: Edward Elgar Publishing
ISBN: 1789903998
Category : Law
Languages : en
Pages : 1504

Get Book Here

Book Description
Both law and economics and intellectual property law have expanded dramatically in tandem over recent decades. This field-defining two-volume Handbook, featuring the leading legal, empirical, and law and economics scholars studying intellectual property rights, provides wide-ranging and in-depth analysis both of the economic theory underpinning intellectual property law, and the use of analytical methods to study it.

How Increased Competition from Generic Drugs Has Affected Prices and Returns in the Pharmaceutical Industry

How Increased Competition from Generic Drugs Has Affected Prices and Returns in the Pharmaceutical Industry PDF Author:
Publisher: U.S. Government Printing Office
ISBN:
Category : Business & Economics
Languages : en
Pages : 94

Get Book Here

Book Description


European Competition Law Annual 2013

European Competition Law Annual 2013 PDF Author: Philip Lowe
Publisher: Bloomsbury Publishing
ISBN: 1509900470
Category : Law
Languages : en
Pages : 688

Get Book Here

Book Description
This volume contains papers presented at the 18th Annual EU Competition Law and Policy Workshop. The papers examine means of balancing effective (public) competition law enforcement and the requirements of legitimate and accountable exercise of public authority. The authors address the design and performance of various enforcement tools at European and national levels, including sanctions and remedies but also distinctive instruments under Regulation 1/2003 (eg commitment procedures) and under the Treaty on the Functioning of the European Union (Article 106(3) when used as a basis for infringement procedures). From the perspective of legitimacy, reflections focus on the implications of fundamental rights standards and general principles of law for the EU's complex and quasi-federal enforcement architecture. Issues that may sometimes escape judicial scrutiny are also discussed, such as how agencies prioritise their activities, and how investigation responsibilities are distributed within the European Competition Network. Effectiveness and legitimacy are then considered in the context of public enforcement cooperation beyond the EU, where international organisations, regional cooperation and a range of formal and informal modes of governance prevail.

Innovation, Economic Development, and Intellectual Property in India and China

Innovation, Economic Development, and Intellectual Property in India and China PDF Author: Kung-Chung Liu
Publisher: Springer Nature
ISBN: 981138102X
Category : Law
Languages : en
Pages : 513

Get Book Here

Book Description
This open access book analyses intellectual property codification and innovation governance in the development of six key industries in India and China. These industries are reflective of the innovation and economic development of the two economies, or of vital importance to them: the IT Industry; the film industry; the pharmaceutical industry; plant varieties and food security; the automobile industry; and peer production and the sharing economy. The analysis extends beyond the domain of IP law, and includes economics and policy analysis. The overarching concern that cuts through all chapters is an inquiry into why certain industries have developed in one country and not in the other, including: the role that state innovation policy and/or IP policy played in such development; the nature of the state innovation policy/IP policy; and whether such policy has been causal, facilitating, crippling, co-relational, or simply irrelevant. The book asks what India and China can learn from each other, and whether there is any possibility of synergy. The book provides a real-life understanding of how IP laws interact with innovation and economic development in the six selected economic sectors in China and India. The reader can also draw lessons from the success or failure of these sectors.